Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study-Reference-Cited by-同舟云学术

Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling study

Published:2024-09 Issue: Volume: Page:
ISSN:1473-3099
Container-title:The Lancet Infectious Diseases
language:en
Short-container-title:The Lancet Infectious Diseases

Author:

Russell Timothy W,Townsley Hermaleigh,Hellewell Joel,Gahir Joshua,Shawe-Taylor Marianne,Greenwood David,Hodgson David,Hobbs Agnieszka,Dowgier Giulia,Penn Rebecca,Sanderson Theo,Stevenson-Leggett Phoebe,Bazire James,Harvey Ruth,Fowler Ashley S,Miah Murad,Smith Callie,Miranda Mauro,Bawumia Philip,Mears Harriet V,Adams Lorin,Hatipoglu Emine,O'Reilly Nicola,Warchal Scott,Ambrose Karen,Strange Amy,Kelly Gavin,Kjar Svend,Papineni Padmasayee,Corrah Tumena,Gilson Richard,Libri Vincenzo,Kassiotis George,Gamblin Steve,Lewis Nicola S,Williams Bryan,Swanton Charles,Gandhi Sonia,Beale Rupert,Wu Mary Y,Bauer David L V,Carr Edward J,Wall Emma C,Kucharski Adam J

Funder

Cancer Research UK

Wellcome Trust

National Institutes of Health

Royal Society

UKRI Medical Research Council

Publisher

Elsevier BV

Reference26 articles.

1. Omicron BA.1-containing mRNA-1273 boosters compared with the original COVID-19 vaccine in the UK: a randomised, observer-blind, active-controlled trial;Lee;Lancet Infect Dis,2023

2. Dichotomy of neutralizing antibody, B cell and T cell responses to SARS-CoV-2 vaccination and protection in healthy adults;Carr;bioRxiv,2023

3. Three-dose vaccination elicits neutralising antibodies against omicron;Wu;Lancet,2022

4. Omicron BA.2.86 cross-neutralising activity in community sera from the UK;Willett;Lancet,2023

5. Immune boosting by B.1.1.529 (omicron) depends on previous SARS-CoV-2 exposure;Reynolds;Science,2022

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Kinetics of neutralising antibodies against SARS-CoV-2 variants;The Lancet Infectious Diseases;2024-09